Patient Controlled Administration of Liquid Acetaminophen

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT06498713
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Pain
  • Pain, Postoperative

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Acetaminophen 650 mg Oral Tablet — DRUG
    650 mg pills
  • Acetaminophen 650mg Liquid — DRUG
    650 mg liquid
  • CADD pump — DEVICE
    Primed and programmed to delivery 650 mg liquid acetaminophen into a medication cup every 4 hours as needed.

Study Details

This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.

Key Dates

Start date
Nov 19, 2024
Status verified
Oct 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
24 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Nurse Administered Acetaminophen
    Participants will receive acetaminophen pills 650 mg every 4 hours as needed (PRN) administered by nurse per standard of care
  • Experimental: CADD pump Administered Acetaminophen (Participant Controlled)
    Participants will receive a CADD pump primed and programmed to deliver 650 mg liquid acetaminophen into a medication cup every 4 hours as needed (PRN).

Primary Outcome Measure

Participant enrollment rate [ Time Frame: up to 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Yale New Haven Hospital at St. Raphael's CampusNew HavenConnecticut06520-

Find similar trials in New Haven, CT

By research site
Yale New Haven Hospital at St. Raphael's Campus· New Haven, CT

Related Studies